How Do Regulatory Bodies Assess Peptide Therapy Safety?
Regulatory bodies meticulously evaluate peptide therapy safety through phased clinical trials and post-market surveillance, ensuring precise biological interventions are both effective and well-tolerated.
∞ Compounded Peptides
∞ Endocrine System
∞ Long-Term Safety